# K161061: IMPAX Volume Viewing 4.0

- Pathway: 510(k) (Traditional)
- Applicant: Agfa Healthcare N.V.
- Decided: Jun 22, 2016 after 68 days
- Product code: LLZ (System, Image Processing, Radiological)
- Device class: 2
- Regulation: 21 CFR 892.2050
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K913770 (1991). 73 ancestors in all.
No later device cites it as a predicate yet.
0 of 74 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K133135: Impax Volume Viewing 3.0, Agfa Healthcare N.V. (2014) Summary page 4.
- K121916: Intuition, Terarecon,Inc. (2013) Summary page 4.

## Indications for use
The Volume Viewing software is a visualization package for PACS workstations. It is intended to support the medical professional in the reading, analysis and diagnosis of DICOM compliant volumetric medical datasets. The software is intended as a general purpose digital medical image processing tool, with optional functionality to facilitate visualization and measurement of vessel features. Other optional functionality is intended for the registration of anatomical (CT) on a second CT dataset or on functional volumetric image data (MR) to facilitate the comparison of various lesions. Volume and distance measurements are intended for evaluation and quantification of tumour measurements, and other analysis and evaluation of both hard and soft tissues. The software also supports interactive segmentation of a region of interest (ROI), has a dedicated tool set for lung lesion segmentation, quantification and follow-up of lesions selected by the user and provides tools to define and edit paths such as centerlines through structures, which may be used to analyze cross-sections of structures, or to provide flythrough visualizations rendered along such centerline. Caution: Web-browser access is available for review purposes. Images accessed through a web-browser (via a mobile device or by other means) should not be used to create a diagnosis, treatment plan, or other decision that may affect patient care.

Source page: https://510kreport.com/device/K161061
Methodology: https://510kreport.com/methodology